Dr. Luis Novaes's TRT claims need more context

What did @drluisnovaes actually say?

Honestly? It is nearly impossible to tell. The transcript captured from this video is incoherent, reading like a machine-translation failure rather than a coherent medical argument. Phrases like "initial executive housing" and "the mechanism exists in the last few years" carry no extractable medical meaning. The hashtags tell us this video was meant to discuss testosterone replacement therapy, but the spoken content as captured does not support a genuine claims analysis.

The creator's bio and hashtag set, including #andrologia, #reposicaohormonal, and #testosterona, situates this within the Brazilian men's health and TRT content space. That context matters, because TRT content on TikTok frequently makes bold claims about testosterone optimization, hypogonadism treatment, and hormone "balancing" that range from mostly accurate to genuinely dangerous. Without a legible transcript, we cannot fairly attribute specific claims to this creator.

Does the science back this up?

There is nothing specific enough here to test against the literature. What we can do is anchor the fact-check in what the science actually says about TRT, the probable subject of the video.

Testosterone replacement therapy for diagnosed hypogonadism is well-supported. Bhasin et al. (2018, New England Journal of Medicine) found significant improvements in sexual function, bone density, and mood in men with low testosterone who received TRT. However, the same research program, the Testosterone Trials, also documented mixed findings on cardiovascular outcomes and no consistent benefit for energy or vitality across all participants. The evidence is real but more nuanced than most TikTok TRT content suggests. Treatment benefit depends heavily on baseline testosterone levels, symptom burden, and the specific formulation used, none of which a short social video can responsibly address.

What did they get wrong (or right)?

Because the transcript is not interpretable, we cannot assign fault or credit to this specific video. That is itself a problem worth naming. If a health creator's content cannot be understood by an audience, either because of poor audio, auto-translation failure, or unclear presentation, it fails the basic job of health communication regardless of how medically accurate the underlying ideas might be.

What we can say is that the hashtag framing around "hormone optimization" is where Brazilian TRT content, like its North American equivalent, often slides from legitimate clinical discussion into marketing territory. Terms like "optimization" imply benefits beyond treating diagnosed deficiency, a position not supported by Snyder et al. (2016, NEJM), whose data showed that men with age-related low testosterone but no clear pathological hypogonadism saw limited and inconsistent benefits from treatment.

What should you actually know?

TRT is a legitimate, regulated treatment for hypogonadism, a condition defined by consistently low testosterone plus symptoms like low libido, fatigue, or reduced bone mass. It is not a general anti-aging or performance enhancement tool, despite how it is frequently framed online.

Key things to understand before engaging with any TRT content on TikTok. First, a diagnosis requires two fasting morning testosterone measurements below established thresholds plus documented symptoms, per Endocrine Society guidelines (Bhasin et al., 2018). Second, formulation matters. Injections, gels, patches, and pellets have different pharmacokinetic profiles, different adherence rates, and different risk profiles. They are not interchangeable. Third, cardiovascular risk remains an open question. The FDA updated its testosterone labeling in 2015 to require a warning about potential cardiovascular risk, and the TRAVERSE trial (Lincoff et al., 2023, NEJM) found non-inferiority to placebo for major cardiac events but also elevated rates of atrial fibrillation and pulmonary embolism. That is not a clean bill of health. Anyone consuming TRT content on social media should bring specific questions to a licensed endocrinologist or urologist, not a comment section or a DM.